158 related articles for article (PubMed ID: 17353865)
1. Reproductive health, obesity, and cardiometabolic risk factors among Samoan women.
Maredia H; Hawley NL; Lambert-Messerlian G; Fidow U; Reupena MS; Naseri T; McGarvey ST
Am J Hum Biol; 2018 May; 30(3):e23106. PubMed ID: 29663637
[TBL] [Abstract][Full Text] [Related]
2. Cardiometabolic consequences of maternal hyperandrogenemia in male offspring.
Zuchowski Y; Dalmasso C; Shawky NM; Reckelhoff JF
Physiol Rep; 2021 Jul; 9(14):e14941. PubMed ID: 34288567
[TBL] [Abstract][Full Text] [Related]
3. Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance.
Georgopoulos NA; Saltamavros AD; Vervita V; Karkoulias K; Adonakis G; Decavalas G; Kourounis G; Markou KB; Kyriazopoulou V
Fertil Steril; 2009 Jul; 92(1):250-5. PubMed ID: 18678372
[TBL] [Abstract][Full Text] [Related]
4. [Proinflammatory cytokines in polycystic ovarian syndrome].
García-Sáenz MR; Ferreira-Hermosillo A; Lobaton-Ginsberg M
Rev Med Inst Mex Seguro Soc; 2022 Aug; 60(5):569-576. PubMed ID: 36049035
[TBL] [Abstract][Full Text] [Related]
5. Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome.
Zhou Y; Lan H; Dong Z; Li W; Qian B; Zeng Z; He W; Song JL
Oxid Med Cell Longev; 2022; 2022():5558599. PubMed ID: 35663203
[TBL] [Abstract][Full Text] [Related]
6. Turmeric extract alleviates endocrine-metabolic disturbances in letrozole-induced PCOS by increasing adiponectin circulation: A comparison with Metformin.
Shah MZUH; Shrivastava VK
Metabol Open; 2022 Mar; 13():100160. PubMed ID: 35005596
[TBL] [Abstract][Full Text] [Related]
7. Korean Red Ginseng alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats via its antiinflammatory and antioxidant activities.
Choi JH; Jang M; Kim EJ; Lee MJ; Park KS; Kim SH; In JG; Kwak YS; Park DH; Cho SS; Nah SY; Cho IH; Bae CS
J Ginseng Res; 2020 Nov; 44(6):790-798. PubMed ID: 33192122
[TBL] [Abstract][Full Text] [Related]
8. Effect of Three Androgen Indexes (FAI, FT, and TT) on Clinical, Biochemical, and Fertility Outcomes in Women with Polycystic Ovary Syndrome.
Zhang D; Gao J; Liu X; Qin H; Wu X
Reprod Sci; 2021 Mar; 28(3):775-784. PubMed ID: 32989632
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome in four phenotypes of PCOS and its relationship with androgenic components among Iranian women: A cross-sectional study.
Zaeemzadeh N; Sadatmahalleh SJ; Ziaei S; Kazemnejad A; Mottaghi A; Mohamadzadeh N; Movahedinejad M
Int J Reprod Biomed; 2020 Apr; 18(4):253-264. PubMed ID: 32494764
[TBL] [Abstract][Full Text] [Related]
10.
Ndeingang EC; Defo Deeh PB; Watcho P; Kamanyi A
Evid Based Complement Alternat Med; 2019; 2019():2965821. PubMed ID: 31217802
[TBL] [Abstract][Full Text] [Related]
11. Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats.
Jang M; Lee MJ; Lee JM; Bae CS; Kim SH; Ryu JH; Cho IH
PLoS One; 2014; 9(2):e87623. PubMed ID: 24520334
[TBL] [Abstract][Full Text] [Related]
12. Metabolic disorders in newly diagnosed young adult female patients with simple virilizing 21-hydroxylase deficiency.
Zhang HJ; Yang J; Zhang MN; Liu CQ; Xu M; Li XJ; Yang SY; Li XY
Endocrine; 2010 Oct; 38(2):260-5. PubMed ID: 20978868
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome in the pediatric population.
Bremer AA
Metab Syndr Relat Disord; 2010 Oct; 8(5):375-94. PubMed ID: 20939704
[TBL] [Abstract][Full Text] [Related]
14. Estrogen sulfotransferase regulates body fat and glucose homeostasis in female mice.
Khor VK; Dhir R; Yin X; Ahima RS; Song WC
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E657-64. PubMed ID: 20682840
[TBL] [Abstract][Full Text] [Related]
15. The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome.
Kassi E; Diamanti-Kandarakis E
J Endocrinol Invest; 2008 Dec; 31(12):1124-31. PubMed ID: 19246981
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of metabolic syndrome among US women of childbearing age.
Ramos RG; Olden K
Am J Public Health; 2008 Jun; 98(6):1122-7. PubMed ID: 18445796
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.
Diamanti-Kandarakis E; Christakou C; Kandarakis H
Minerva Endocrinol; 2007 Mar; 32(1):35-47. PubMed ID: 17353865
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
[TBL] [Abstract][Full Text] [Related]
19. Obesity and the polycystic ovary syndrome.
Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
